Latexin Protein (LXN) (AA 1-222)
-
- Target See all Latexin (LXN) Proteins
- Latexin (LXN)
- Protein Type
- Recombinant
- Protein Characteristics
- AA 1-222
-
Origin
- Human
-
Source
- Escherichia coli (E. coli)
- Application
- SDS-PAGE (SDS)
- Characteristics
- Latexin, 1-222aa, Human, Recombinant, E.coli
- Purity
- > 95 % by SDS - PAGE
- Top Product
- Discover our top product LXN Protein
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/ml (determined by Bradford assay)
- Buffer
- Liquid. In 20 mM Tris-HCl buffer (pH 7.5) containing 50mM NaCl, 10% glycerol
- Storage
- 4 °C
-
- Target
- Latexin (LXN)
- Alternative Name
- Latexin (LXN Products)
- Synonyms
- wu:fk66c02 Protein, zgc:103612 Protein, LXN Protein, lxn Protein, ECI Protein, TCI Protein, latexin Protein, lxn Protein, LXN Protein, Lxn Protein
- Background
- Latexin, a carboxypeptidase A inhibitor, is highly expressed in heart, prostate, ovary, kidney, pancrease, and colon, moderaqte or low in other tissues including brain. Latexin has no detectable sequence similarity with plant and parasite inhibitors, but it is related to a human putative tumor suppressor protein, TIG1. It is down-regulated in the presenilin-1-deficient mouse brain, thus putatively playing a role in Alzheimer's disease. Recombinant human Latexin protein was expressed in E.coli and purified by using conventional chromatography. Synonyms: LXN, ECI, TCI, MUM, Endogenous carboxypeptidase inhibitor, Latexin, Latexin protein, Tissue carboxypeptidase inhibitor. NCBI no.: NP_064554
- Molecular Weight
- 25.7 kDa (222aa), confirmed by MALDI-TOF.
-